BDSX Form 4: 602 RSUs Vest for CHCO; Tax-Withholding Sale of 228 Shares
Rhea-AI Filing Summary
Chris Vazquez, Chief Accounting Officer of Biodesix, Inc. (BDSX), reported equity changes tied to vesting of restricted stock units (RSUs). On 08/12/2025 the reporting person was issued 602 RSUs, each representing a contingent right to one share of common stock; after vesting and automatic sales to cover taxes, the reporting person beneficially owned 18,603 shares. On 08/13/2025 the filing shows an automatic sale of 228 shares at a weighted average price of $0.4163 (sales occurred within a $0.4076–$0.43 range) resulting in 18,375 shares beneficially owned following the transactions. The RSUs vest in 16 successive quarterly installments beginning February 8, 2022, are generally conditioned on continued service, and have no expiration date.
Positive
- RSU vesting demonstrates continued equity-based compensation aligning the Chief Accounting Officer's interests with shareholders
- Accurate disclosure of weighted-average sale price and sale range provides transparency about the tax-withholding mechanics
Negative
- Automatic sale reduced direct holdings by 228 shares, lowering beneficial ownership from 18,603 to 18,375 shares
Insights
TL;DR: Routine executive compensation vesting with small tax-cover sale; no material change to control or firm valuation.
The transactions disclosed are a standard administrative outcome of RSU vesting: the issuer delivered 602 RSUs to the reporting person and a subset of shares (228) were sold automatically to satisfy tax-withholding obligations at a weighted average price of $0.4163. The remaining beneficial ownership (18,375 shares) suggests no significant divestiture that would alter governance or signal a broad liquidity event. The RSU schedule (16 quarterly installments, no expiration) indicates ongoing compensation rather than an extraordinary grant.
TL;DR: Disclosure aligns with Section 16 reporting norms; sale was for tax withholding on vested awards, not open-market disposition intent.
The filing properly reports the vesting of equity awards and the broker-assisted sale to cover tax obligations. The limited size of the sale relative to total beneficial ownership and the stated mechanics (automatic sale across a price range) are consistent with routine administrative withholding. There is no indication in the filing of changes to officer status or any coordinated sale program.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 228 | $0.4163 | $94.92 |
| Exercise | Restricted Stock Units | 602 | $0.00 | -- |
| Exercise | Common Stock | 602 | $0.00 | -- |
Footnotes (1)
- Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
